R&D Changing Faces: Pharma and biotech hires from January 2024 It’s a new year, so we’re kicking it off with the relaunch of Changing Faces after we lost the thread a bit last year.
News Tuneable peptide biotech Parabilis files IPO Fresh from agreeing a wide-ranging alliance with Regeneron worth up to $2.3bn, Parabilis has joined the IPO queue.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
